| Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection DS Khoury, D Cromer, A Reynaldi, TE Schlub, AK Wheatley, JA Juno, ... Nature medicine 27 (7), 1205-1211, 2021 | 3488 | 2021 |
| Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization S Cele, L Jackson, DS Khoury, K Khan, T Moyo-Gwete, H Tegally, JE San, ... Nature 602 (7898), 654-656, 2022 | 999 | 2022 |
| mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern RR Goel, MM Painter, SA Apostolidis, D Mathew, W Meng, AM Rosenfeld, ... Science 374 (6572), abm0829, 2021 | 707 | 2021 |
| Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis D Cromer, M Steain, A Reynaldi, TE Schlub, AK Wheatley, JA Juno, ... The Lancet Microbe 3 (1), e52-e61, 2022 | 473 | 2022 |
| SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection S Cele, L Jackson, DS Khoury, K Khan, T Moyo-Gwete, H Tegally, JE San, ... MedRxiv, 2021 | 363 | 2021 |
| Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19 AK Wheatley, JA Juno, JJ Wang, KJ Selva, A Reynaldi, HX Tan, WS Lee, ... Nature communications 12 (1), 1162, 2021 | 356 | 2021 |
| A quantitative model of honey bee colony population dynamics DS Khoury, MR Myerscough, AB Barron PloS one 6 (4), e18491, 2011 | 316 | 2011 |
| Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection D Cromer, JA Juno, D Khoury, A Reynaldi, AK Wheatley, SJ Kent, ... Nature Reviews Immunology 21 (6), 395-404, 2021 | 261 | 2021 |
| Modelling food and population dynamics in honey bee colonies DS Khoury, AB Barron, MR Myerscough PloS one 8 (5), e59084, 2013 | 191 | 2013 |
| Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine RR Goel, MM Painter, KA Lundgreen, SA Apostolidis, AE Baxter, JR Giles, ... Cell 185 (11), 1875-1887. e8, 2022 | 161 | 2022 |
| Functional cure of HIV: the scale of the challenge MP Davenport, DS Khoury, D Cromer, SR Lewin, AD Kelleher, SJ Kent Nature Reviews Immunology 19 (1), 45-54, 2019 | 121 | 2019 |
| Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models DS Khoury, AK Wheatley, MD Ramuta, A Reynaldi, D Cromer, ... Nature Reviews Immunology 20 (12), 727-738, 2020 | 111 | 2020 |
| Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast? SJ Kent, DS Khoury, A Reynaldi, JA Juno, AK Wheatley, E Stadler, ... Nature Reviews Immunology 22 (6), 387-397, 2022 | 107 | 2022 |
| Predicting the efficacy of variant-modified COVID-19 vaccine boosters DS Khoury, SS Docken, K Subbarao, SJ Kent, MP Davenport, D Cromer Nature Medicine 29 (3), 574-578, 2023 | 63 | 2023 |
| SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern A Aggarwal, AO Stella, G Walker, A Akerman, V Milogiannakis, F Brilot, ... medrxiv, 2021.12. 14.21267772, 2021 | 63 | 2021 |
| Correlates of protection, thresholds of protection, and immunobridging among persons with SARS-CoV-2 infection DS Khoury, TE Schlub, D Cromer, M Steain, Y Fong, PB Gilbert, ... Emerging Infectious Diseases 29 (2), 381, 2023 | 58 | 2023 |
| A meta-analysis of early results to predict vaccine efficacy against Omicron DS Khoury, M Steain, JA Triccas, A Sigal, MP Davenport, D Cromer MedRxiv, 2021.12. 13.21267748, 2021 | 57 | 2021 |
| Safety and Reproducibility of a Clinical Trial System Using Induced Blood Stage Plasmodium vivax Infection and Its Potential as a Model to Evaluate Malaria … P Griffin, C Pasay, S Elliott, S Sekuloski, M Sikulu, L Hugo, D Khoury, ... PLoS neglected tropical diseases 10 (12), e0005139, 2016 | 52 | 2016 |
| SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses M Koutsakos, A Reynaldi, WS Lee, J Nguyen, T Amarasena, G Taiaroa, ... Immunity 56 (4), 879-892. e4, 2023 | 45 | 2023 |
| Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis D Cromer, M Steain, A Reynaldi, TE Schlub, SR Khan, SC Sasson, ... Nature Communications 14 (1), 1633, 2023 | 45 | 2023 |
Miles DavenportKirby Institute, UNSWBestätigte E-Mail-Adresse bei unsw.edu.au
